379 related articles for article (PubMed ID: 12180926)
21. Escherichia coli global gene expression in urine from women with urinary tract infection.
Hagan EC; Lloyd AL; Rasko DA; Faerber GJ; Mobley HL
PLoS Pathog; 2010 Nov; 6(11):e1001187. PubMed ID: 21085611
[TBL] [Abstract][Full Text] [Related]
22. Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation.
Ong CL; Ulett GC; Mabbett AN; Beatson SA; Webb RI; Monaghan W; Nimmo GR; Looke DF; McEwan AG; Schembri MA
J Bacteriol; 2008 Feb; 190(3):1054-63. PubMed ID: 18055599
[TBL] [Abstract][Full Text] [Related]
23. Multiple genes repress motility in uropathogenic Escherichia coli constitutively expressing type 1 fimbriae.
Simms AN; Mobley HL
J Bacteriol; 2008 May; 190(10):3747-56. PubMed ID: 18359812
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of the role of yfiR in the ability of Escherichia coli CFT073 to control cellular cyclic dimeric GMP levels and to persist in the urinary tract.
Raterman EL; Shapiro DD; Stevens DJ; Schwartz KJ; Welch RA
Infect Immun; 2013 Sep; 81(9):3089-98. PubMed ID: 23774594
[TBL] [Abstract][Full Text] [Related]
25. In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection.
Lim JK; Gunther NW; Zhao H; Johnson DE; Keay SK; Mobley HL
Infect Immun; 1998 Jul; 66(7):3303-10. PubMed ID: 9632599
[TBL] [Abstract][Full Text] [Related]
26. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073.
Bryan A; Roesch P; Davis L; Moritz R; Pellett S; Welch RA
Infect Immun; 2006 Feb; 74(2):1072-83. PubMed ID: 16428754
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic Potential.
Shea AE; Frick-Cheng AE; Smith SN; Mobley HLT
mSystems; 2022 Dec; 7(6):e0082722. PubMed ID: 36445110
[TBL] [Abstract][Full Text] [Related]
28. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract.
Lane MC; Alteri CJ; Smith SN; Mobley HL
Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16669-74. PubMed ID: 17925449
[TBL] [Abstract][Full Text] [Related]
29. Role of the K2 capsule in Escherichia coli urinary tract infection and serum resistance.
Buckles EL; Wang X; Lane MC; Lockatell CV; Johnson DE; Rasko DA; Mobley HL; Donnenberg MS
J Infect Dis; 2009 Jun; 199(11):1689-97. PubMed ID: 19432551
[TBL] [Abstract][Full Text] [Related]
30. Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection.
Snyder JA; Lloyd AL; Lockatell CV; Johnson DE; Mobley HL
Infect Immun; 2006 Feb; 74(2):1387-93. PubMed ID: 16428790
[TBL] [Abstract][Full Text] [Related]
31. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
Mobley HL; Island MD; Massad G
Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
[TBL] [Abstract][Full Text] [Related]
32. PhoU enhances the ability of extraintestinal pathogenic Escherichia coli strain CFT073 to colonize the murine urinary tract.
Buckles EL; Wang X; Lockatell CV; Johnson DE; Donnenberg MS
Microbiology (Reading); 2006 Jan; 152(Pt 1):153-160. PubMed ID: 16385125
[TBL] [Abstract][Full Text] [Related]
33. Involvement of mismatch repair in the reciprocal control of motility and adherence of uropathogenic Escherichia coli.
Cooper LA; Simmons LA; Mobley HL
Infect Immun; 2012 Jun; 80(6):1969-79. PubMed ID: 22473602
[TBL] [Abstract][Full Text] [Related]
34. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.
Li X; Johnson DE; Mobley HL
Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487
[TBL] [Abstract][Full Text] [Related]
35. The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation.
Ulett GC; Mabbett AN; Fung KC; Webb RI; Schembri MA
Microbiology (Reading); 2007 Jul; 153(Pt 7):2321-2331. PubMed ID: 17600076
[TBL] [Abstract][Full Text] [Related]
36. Do type 1 fimbriae promote inflammation in the human urinary tract?
Bergsten G; Wullt B; Schembri MA; Leijonhufvud I; Svanborg C
Cell Microbiol; 2007 Jul; 9(7):1766-81. PubMed ID: 17359236
[TBL] [Abstract][Full Text] [Related]
37. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine.
Roos V; Ulett GC; Schembri MA; Klemm P
Infect Immun; 2006 Jan; 74(1):615-24. PubMed ID: 16369018
[TBL] [Abstract][Full Text] [Related]
38. Uropathogenic Escherichia coli CFT073 is adapted to acetatogenic growth but does not require acetate during murine urinary tract infection.
Anfora AT; Halladin DK; Haugen BJ; Welch RA
Infect Immun; 2008 Dec; 76(12):5760-7. PubMed ID: 18838520
[TBL] [Abstract][Full Text] [Related]
39. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.
Lane MC; Lockatell V; Monterosso G; Lamphier D; Weinert J; Hebel JR; Johnson DE; Mobley HL
Infect Immun; 2005 Nov; 73(11):7644-56. PubMed ID: 16239569
[TBL] [Abstract][Full Text] [Related]
40. Covert operations of uropathogenic Escherichia coli within the urinary tract.
Bower JM; Eto DS; Mulvey MA
Traffic; 2005 Jan; 6(1):18-31. PubMed ID: 15569242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
